In the context of the COVID-19 pandemic, the EBMT has put together a series of live webinars with other sister organisations.
COVID-19 Recorded Webinars for Nurses
The Nurses Group has planned a series of recorded webinars. They will be open and available on this webpage.
Palliative Care guidance for patients with severe COVID-19
In this recorded webinar, Dr Ruth Ting gives practical guidance about symptom management and holistic care for patients with severe COVID-19.
Learning objectives:
- How to manage breathlessness and anxiety in severe COVID-19
- How to make a parallel plan for patients who are ill enough that they might die
- Communication: what words might be helpful?
Speaker:
Dr Ruth Ting. King’s College Hospital, London. UK.
Presentation slides and recording
Click HERE to view the presentation slides.
For any queries please contact: elearning@ebmt.org
Psychological impact of COVID-19 pandemic on nurses: experiences and tips
In this recorded webinar we would like to help nurses to cope with the impact that COVID-19 pandemic has had in our professional and personal lives, sharing experiences, feelings and providing psychological strategies.
Learning objectives:
- To share nurses’ personal and professional experiences of the impact of coping with COVID-19 pandemic: experiences of nurse managers, nurses at haematology units, and relocated nurses to COVID units
- To provide nurses with psychological strategies to cope with the current situation of working "at the trenches"
Speakers:
Julia Ruíz Pato. Quality manager and Transplant coordinator. Hospital Infantil Universitario Niño Jesús de Madrid. Spain
Isabel Salcedo de Diego, RN, PhD. Research Nurse. Hospital Universitario Puerta de Hierro Majadahonda. Spain
Dr Troy C Chase. Clinical Psychologist. Imperial College Healthcare - Hammersmith Hospital. London, UK.
Presentation slides and recording
For any queries please contact: elearning@ebmt.org
Past webinars
CAR-T Cell and COVID-19 and how and when to restart the transplant program (EBMT/ASTCT)
This webinar was jointly organized by EBMT and ASTCT.
In this webinar experts from EBMT and ASTCT reported on feasibility and prevention measures of CAR-T cell treatment during COVID-19 pandemic in Europe and the US and in the second part experts gave recommendations when to restart the transplant program and when chemotherapy and/or transplant can be admitted safe in previous COVID-19 infected patients.
Learning objectives:
- to describe the risk of CAR-T cell treatment during COVID-19 pandemic
- to describe prevention measures during COVID-19 pandemic for patients undergoing CAR-T cell treatment
- to learn when to restart the transplant program in heavily affect COVID-19 regions
- to learn about the timing of chemotherapy/transplantation in hematological patients previously COVID-19 infected
Moderators:
- Nicolaus Kröger, MD: Professor of Medicine, Director Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Martinistrasse 52 D-20246 Hamburg/Germany
- Pavan Reddy, MD. Frances and Victor Ginsberg Professor of Hematology/Oncology, Professor of Medicine and Pediatrics, Chief, Division of Hematology-Oncology, Deputy Director, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Speakers:
- Christian Chabannon, MD, Ph.D. Head & Qualified person. Centre de Thérapie Cellulaire. Institut Paoli-Calmettes. Comprehensive Cancer Centre & Professor of Medicine in Cell Biology. Aix-Marseille Université School of Medicine Marseille. France
- Nirali N. Shah, MD, MHSc. NIH Lasker Clinical Research Scholar, NIH Distinguished Scholar Head, Hematologic Malignancies Section Pediatric Oncology Branch, National Cancer Institute. USA
- Marco Mielcarek, MD. Medical Director, Adult Blood and Marrow Transplantation, Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance. Professor, FHCRC. Professor of Medicine, Dept. of Medical Oncology, University of Washington. USA
- Fabio Ciceri, MD. Deputy Scientific Director Clinical Research, IRCCS Ospedale San Raffaele Head, Hematology and Hematopoietic Stem Cell Transplantation Unit Full professor, Università Vita Salute San Raffaele. Italy
Presentation slides and recording
For any queries please contact: elearning@ebmt.org
Treatment options of COVID-19 patients with focus on stem cell transplantation and CAR-T cells (EBMT/ASTCT)
This webinar was jointly organized by EBMT and ASTCT.
This webinar covered the following topics: antivirals, chloroquine and anti-inflammatory drugs, immunoglobulins and hyperimmune plasma, vaccines, and the interpretation of serological assays.
Learning objectives:
- to describe different treatment options and ongoing studies for COVID-19 patients
- to get familiar with side effects of different COVID 19 treatments in immunocompromised patients
- to get an update of Vaccination strategies and of the clinical relevance of antibodies response
Moderators:
- Nicolaus Kröger, MD: Professor of Medicine, Director Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Martinistrasse 52 D-20246 Hamburg/Germany
- Pavan Reddy, MD: Frances and Victor Ginsberg Professor of Hematology/Oncology, Professor of Medicine and Pediatrics, Chief, Division of Hematology-Oncology, Deputy Director, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Speakers:
- Alpana Waghmare, MD: Assistant Professor, Pediatric Infectious Diseases, University of Washington/Seattle Children's Hospital, Assistant Member, Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center
- Malgorzata Mikulska MD, PhD: Associate Professor of Infectious Diseases University of Genova, Department of Health Sciences, Ospedale Policlinico San Martino, Italy
- Zenia Papanicolaou, MD: Member, Infectious Disease Service Memorial Sloan Kettering Cancer Center Professor, Weill Cornell Medical College Cornell University New York, USA
- Per Ljungman MD, PhD: Prof (em) of Hematology Karolinska Institutet Senior Physician Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation Karolinska University Hospital Stockholm, Sweden
Presentation slides and recording
For any queries please contact: elearning@ebmt.org
Strategies to prevent and handle outbreak of COVID-19 on transplant wards (EBMT/ASTCT)
This webinar was jointly organized by EBMT and ASTCT.
Expert doctors from hot spot areas commented on their experience on managing COVID19 outbreak. Besides, they gave recommendations to prevent an outbreak on transplant wards according to their experience
Learning objectives:
- Getting familiar with options and possibilities to prevent and handle the outbreak of COVID-19 on a transplant ward properly
- To know the first results of an EBMT survey regarding outcome transplanted patients with COVID-19 infection
Moderators:
- Nicolaus Kröger, MD: Professor of Medicine, Director Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Martinistrasse 52 D-20246 Hamburg/Germany
- Pavan Reddy, MD: Frances Victor Professor of Medicine, Professor of Medicine and Pediatrics, Chief, Division of Hematology-Oncology, Deputy Director, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Speaker Panel:
- Dr. He Huang MD, Ph.D.: President and Professor Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- Dr. Rafael de la Cámara: Haematologist consultor, Haematology Department, Hospital Universitario de la Princesa, Madrid (Spain)
- Zenia Papanicolaou, MD: Member, Infectious Disease Service, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medical College Cornell University, New York, USA
- Steven A. Pergam, MD, MPH: Medical Director of Infection Prevention, Seattle Cancer Care Alliance, Associate Member, Vaccine and Infectious Disease & Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Associate Professor, Department of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Adjunct Associate Professor, Department of Epidemiology, School of Public Health, University of Washington
- Prof Per Ljungman: Professor (em) of Hematology Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation Karolinska University Hospital and Karolinska Institutet Stockholm, Sweden
For any queries please contact: elearning@ebmt.org
Presentation slides and recording
How to ensure unrelated donor grafts and CAR-T cells products during Corona pandemic (EBMT/WMDA)
This webinar organized by EBMT and WMDA was aimed at transplant center physicians, search coordinators, and transplant coordinators, who are coordinating unrelated transplants for their patients.
We outlined the current state of knowledge regarding the COVID-19 pandemic and its impact on donor care and the provision of unrelated stem cell transplants. Aspects were discussed and a number of useful reference resources were presented.
Learning objectives:
- To inform healthcare professionals about the current state of knowledge regarding the COVID-19 pandemic and its impact on the provision of unrelated stem cell transplants as of 6 April 2020
- To identify good sources of information in the area of donor care in the COVID-19 pandemic
- To relay our current understanding of the impact of COVID-19 on transport, and the provision of CT samples and stem cell products.
- To know what you can do as a healthcare professional to get an unrelated transplant in your center or to work on alternative solutions (e.g. cord blood transplant or cryopreserved products)
- To provide information about what EBMT and WMDA are doing in the COVID-19 pandemic
Speaker panel:
- Christian CHABANNON, MD, Ph.D, Chair. EBMT Cell Therapy & Immunobiology Working Party
- Univ. Prof. Dr. Nina Worel, EBMT Donor Outcome Committee Chair
- Bronwen Shaw, Scientific Director at CIBMTR and board member Donor Care for WMDA
- Ann O’Leary, Assistant Director, Donor and Transplantation Services at Anthony Nolan, also board committee member Supporting Global Development for WMDA
- Mirjam Fechter, MD at Matchis and WMDA
- Gabi Rall, Director Medical Business Development at DKMS and member of the WMDA Emergency Task Force
For any queries please contact: elearning@ebmt.org
Presentation slides and recording
COVID-19 and me: an EBMT webinar for patients and caregivers
This third live webinar was hosted by Dr Helene Schoemans and Ms. Bregje Verhoeven.
This webinar was organized by the Patient Advocacy Committee and the Patient Engagement Taskforce of the Transplant Complications Working Party. It is aimed at patients, and caregivers of patients, who have undergone or are scheduled to receive a hematopoietic stem cell transplantation or cellular therapy. We outlined the current state of knowledge regarding the COVID-19 pandemic and its impact on patient care. Self-management aspects were discussed and a number of useful reference resources were presented.
Learning objectives:
- To inform patients and care-givers about the current state of knowledge regarding the COVID-19 pandemic and its impact on cell therapy as of 3 April, 2020
- To identify good sources of medical information about COVID-19
- To relay our current understanding of the impact of COVID-19 on cancer care, stem cell transplantation and cell therapy
- To know what you can do as patient/caregiver to get through the COVID-19 pandemic
- To provide information about what EBMT is doing in the COVID-19 pandemic
After the live webinar, there was 10 minutes for questions from the audience.
For any queries please contact: elearning@ebmt.org
Presentation slides and recording
ITALIAN
FRENCH
Click HERE to view the presentation slides.
Resources
Useful and updated information for patients regarding the COVID-19 can be found HERE.
Get News & Updates
Please fill in this form to get EBMT news and updates
COVID-19 and Hematology Patient Care (EBMT/EHA)
The 2nd webinar on COVID-19 took place on Wednesday 1 April. The European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA) organized jointly this webinar.
The speakers were:
• Prof Alessandro Rambaldi - U.O. Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy
• Prof Jose M Ribera - Josep Carreras Leukemia, Research Institute, Barcelona, Spain
• Prof Dr Marie von Lilienfeld-Toal - Universitätsklinikum Jena, Germany
• Prof Malgorzata Mikulska - University of Genova, Italy
Presentation slides and recording
For any queries please contact: elearning@ebmt.org
COVID-19 in stem cell transplant patients. What do we know?
The 1st webinar on COVID-19 by Dr Per Ljungman took place on Friday 20 March. The recorded version of the live webinar is available for viewing. Watch the video below. Or click on the blue button below to see the slides.
The webinar covered the following topics:
- Short introduction into the topic
- What is currently known about the virus
- Prevention strategies focusing on transplanted patient and donors
- Treatment options
- Practical consideration
Presentation slides and recording
Click HERE to view the presentation.
For any queries please contact: elearning@ebmt.org